Antares Pharma (ATRS) Financials

$5.59

$0.00 (0.00%)

As on 24-May-2022 09:30EDT

Market cap

$955 Mln

Revenue (TTM)

$183 Mln

P/E Ratio

24.1

P/B Ratio

5.4

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Operating Revenue	183.46	183.98	149.60	123.86	63.55	54.52
Cost of Revenue	70.60	68.28	63.10	50.48	31.07	27.47
Gross Profit	112.85	115.70	86.50	73.39	32.49	27.05
Operating Expenses	112.69	156.64	72.88	72.40	49.09	43.50
Operating Profit (EBIT)	57.72	65.93	13.62	0.99	-4.10	-16.45
Other Income	-0.15	-0.05	0.09	0.53	0.26	1.13
Profit before Tax	54.75	62.27	9.92	-2.03	-6.52	-16.74
Provision for Tax	12.29	15.98	-46.28	--	--	--
Profit after Tax (Net Income)	42.46	46.29	56.20	-2.03	-6.52	-16.74
Minority Interest	--	--	--	--	--	--
Consolidated Profit	40.18	46.29	56.20	-2.03	-6.52	-16.74

Liabilities ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Shareholder's Funds	175.77	175.76	119.12	54.50	39.00	33.55
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	24.16	22.82	30.21	45.84	22.08	25.06
Current Liabilities	55.73	58.93	63.21	32.42	27.19	15.73
Total Liabilities	311.39	257.51	212.53	132.75	88.28	74.34

Assets ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Non-Current Assets	84.07	78.03	85.94	24.31	16.97	18.80
Current Assets	171.59	161.71	126.59	108.45	71.31	55.54
Total Assets	311.39	257.51	212.53	132.75	88.28	74.34
Total Debt*	25.49	23.95	42.10	41.64	25.13	24.86
Net Current Assets	115.86	115.34	63.39	76.03	44.12	39.80

Cashflow ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Cash From Operating Activities	--	36.62	21.32	-10.62	-17.32	-23.09
Cash Flow from Investing Activities	--	-3.85	8.17	-20.00	11.61	-4.33
Cash from Financing Activities	--	-19.99	0.45	25.92	7.05	26.27
Net Cash Inflow / Outflow	--	12.78	29.93	-4.69	1.33	-1.15

Financials Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Adjusted EPS ($)	0.24	0.26	0.33	-0.01	-0.04	-0.11
Cash EPS ($)	--	0.29	0.35	0.00	-0.02	-0.09
Adjusted Book Value ($)	--	1.00	0.70	0.33	0.25	0.22
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	0.21	0.13	-0.07	-0.11	-0.15
Free Cash Flow per Share ($)	--	0.17	0.04	-0.08	-0.12	-0.16

Profitability Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
ROCE (%)	--	25.65	43.67	-2.53	-10.63	-32.32
ROE (%)	26.82	31.40	64.74	-4.34	-17.96	-42.51
ROA (%)	14.11	19.70	32.55	-1.83	-8.01	-23.81
EBIT Margin (%)	30.97	33.85	9.16	1.23	-6.04	-28.10
Net Margin (%)	23.16	25.17	37.55	-1.63	-10.21	-30.09
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Revenue Growth (%)	15.67	0.23	0.21	0.95	0.17	0.04
EBIT Growth (%)	179.19	354.27	800.66	139.64	74.93	36.80
Net Profit Growth (%)	-31.90	-17.64	2,872.62	68.89	61.09	31.21
EPS Growth (%)	-33.85	-0.20	27.58	0.70	0.61	0.32
Book Value Growth (%)	43.35	--	--	--	--	--

Valuation Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Price / Earnings	24.09	13.50	12.07	-377.95	-65.55	-18.54
Price / Book Value	5.43	3.55	5.69	14.06	10.95	9.25
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	14.93	8.79	40.85	186.82	-380.17	-22.98
Close Price ($)	4.10	3.57	3.99	4.70	2.72	1.99
High Price ($)	4.63	5.07	4.65	5.13	3.93	4.09
Low Price ($)	3.11	3.11	1.60	2.60	1.85	1.58
Market Cap ($ Cr)	955.06	--	--	--	--	--

Solvency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debt to Equity	0.10	0.14	0.35	0.76	0.64	0.74
Short term debt to equity ratio	0.01	0.02	0.15	0.02	0.08	0.74
Current Ratio	3.08	2.74	2.00	3.35	2.62	3.53
Quick Ratio	2.87	2.55	1.71	2.85	2.20	2.94
Interest Coverage	20.39	--	3.62	0.43	-1.44	-10.77

Operating Efficiency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debtors to sales (%)	50.85	45.12	33.66	34.96	46.29	21.79
Asset Turnover	0.61	0.78	0.87	1.12	0.78	0.78
Receivable days	--	132.39	114.35	107.23	118.67	70.19
Inventory Days	--	79.60	99.03	98.96	121.25	97.09
Payable days	--	88.93	84.22	86.98	100.48	92.04
Cash Conversion Cycle	--	123.05	129.16	119.20	139.44	75.24

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.